IRCT20090117001556N150尚未招募2 期
Rosiglitazone as an adjuvant therapy to risperidone in children with autism spectrum disorder: a randomized placebo-controlled double-blind clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 11 years（—）
- 性别
- All
入选标准
- •Diagnosis of autism based on DSM5 and ABC-C
排除标准
- •Medically active disease
- •The presence of another psychological diagnosis in DSM 3 axis
- •History of previous sensitivity and intolerance to rosiglitazone
- •History of seizures and liver disorders
- •Taking antipsychotic drugs such as Risperidone before entering the study
- •Alanine aminotransferase (ALT) level < 2.5 at the beginning of the study
研究者
相似试验
尚未招募
2 期
The effect of Rosiglitazone in the treatment of depressioIRCT20090117001556N152Tehran University of Medical Sciences50
已完成
2 期
pioglitazone in the treatment of autismChildhood autism.Childhood autismIRCT201202281556N37Tehran University of Medical Sciences40
尚未招募
2 期
The effect of Rosiglitazone on negative symptoms in schizophreniaSchizophreniaIRCT20090117001556N159niversity of social welfare and rehabilitation sciences50
已完成
2 期
Riluzole in the treatment of autismChildhood autism.Childhood autismIRCT201107281556N27Tehran University of Medical Sciences40
已完成
不适用
Does treatment with rosiglitazone result in improved pancreatic beta-cell function as compared to glimepiride in metformin treated diabetes type 2 patients?Diabetes mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetes mellitusISRCTN52245496Academic Medical Centre (AMC) (The Netherlands)22